Tag Archive for: financing

F2G Announces $70 Million Financing to Advance Development and Commercialization of New Antifungal Agent Olorofim

New Investment from Forbion and Sofinnova Partners MANCHESTER, UK, 4 August 2022 – F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical need, today announces a $70 million financing. The financing was co-led by new investors Forbion and Sofinnova Partners […]

Ariceum Therapeutics Launches with EUR 25M Series A to Advance Lead Asset, Satoreotide, for the Treatment of Low- and High-Grade Neuroendocrine Cancers

Oversubscribed financing co-led by HealthCap and EQT Life Sciences (formerly LSP); joined by Pureos Bioventures Developing novel drugs for systemic targeted radiation therapy (STRT) Proceeds will be used to advance lead radiopharmaceutical product, satoreotide, for the treatment of neuroendocrine cancers and certain other aggressive, hard-to-treat cancers Led by industry veteran Manfred Rüdiger as CEO, and world-renowned […]

ViCentra closes EUR 65M (USD 74M) Series C funding to expand the footprint of world’s smallest insulin pump across Europe

New investor, Partners in Equity – joins existing investors Health Innovations, INKEF Capital LSP and Invest-NL Proceeds will be used for commercial European launch of updated Kaleido insulin patch pump system including automated insulin delivery (AID) or closed loop December 16, 2021, Utrecht, The Netherlands – ViCentra, the company behind Kaleido, the world’s smallest and lightest wearable […]

Depixus Raises USD 35.4M in Series A Financing

The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. MAGNA™ is set to unlock the field of dynamic genomics. Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by funds bringing additional experience in the life science sector. Paris, […]